Boston Scientific (BSX) Competitors $104.42 -0.22 (-0.21%) Closing price 05/22/2025 03:59 PM EasternExtended Trading$104.98 +0.56 (+0.54%) As of 05/22/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STEShould you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry. Boston Scientific vs. Abbott Laboratories Intuitive Surgical Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking. Do insiders & institutionals have more ownership in ABT or BSX? 75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by insiders. Comparatively, 0.5% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is ABT or BSX more profitable? Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories31.95% 20.74% 11.19% Boston Scientific 11.07%17.80%9.85% Does the media prefer ABT or BSX? In the previous week, Boston Scientific had 8 more articles in the media than Abbott Laboratories. MarketBeat recorded 49 mentions for Boston Scientific and 41 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.37 beat Boston Scientific's score of 1.35 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 32 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 36 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, ABT or BSX? Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$42.34B5.40$13.40B$7.7117.05Boston Scientific$17.55B8.80$1.85B$1.3776.22 Which has more risk and volatility, ABT or BSX? Abbott Laboratories has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Does the MarketBeat Community favor ABT or BSX? Boston Scientific received 117 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 70.00% of users gave Abbott Laboratories an outperform vote while only 69.96% of users gave Boston Scientific an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes95270.00% Underperform Votes40830.00% Boston ScientificOutperform Votes106969.96% Underperform Votes45930.04% Do analysts rate ABT or BSX? Abbott Laboratories presently has a consensus target price of $142.59, indicating a potential upside of 8.46%. Boston Scientific has a consensus target price of $114.87, indicating a potential upside of 10.01%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Boston Scientific is more favorable than Abbott Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.84Boston Scientific 0 Sell rating(s) 0 Hold rating(s) 22 Buy rating(s) 2 Strong Buy rating(s) 3.08 SummaryBoston Scientific beats Abbott Laboratories on 10 of the 19 factors compared between the two stocks. Get Boston Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSX vs. The Competition Export to ExcelMetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$154.48B$4.43B$5.34B$19.32BDividend YieldN/A43.63%5.21%3.83%P/E Ratio83.5429.2026.8534.57Price / Sales8.8065.63387.2334.85Price / Cash28.8651.0838.2517.51Price / Book7.006.196.774.69Net Income$1.85B$67.60M$3.23B$1.02B7 Day Performance-0.20%-0.58%1.81%-1.73%1 Month Performance9.96%18.10%10.93%7.51%1 Year Performance38.54%21.59%17.15%4.13% Boston Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSXBoston Scientific4.5694 of 5 stars$104.42-0.2%$114.87+10.0%+38.5%$154.48B$17.55B83.5445,000Positive NewsAnalyst ForecastOptions VolumeABTAbbott Laboratories4.8724 of 5 stars$135.38+0.4%$142.59+5.3%+25.4%$235.54B$42.34B17.70115,000News CoveragePositive NewsISRGIntuitive Surgical4.271 of 5 stars$560.42-0.6%$598.95+6.9%+35.4%$200.86B$8.71B87.4312,100Positive NewsAnalyst ForecastSYKStryker4.9219 of 5 stars$393.87-0.1%$427.05+8.4%+12.8%$150.34B$23.22B50.7651,000Positive NewsAnalyst ForecastMDTMedtronic4.7752 of 5 stars$86.90+0.5%$96.14+10.6%-5.6%$111.45B$33.20B26.4195,000Trending NewsEarnings ReportDividend IncreaseAnalyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.9803 of 5 stars$176.54+0.6%$231.44+31.1%-26.6%$50.60B$20.87B29.3377,000Positive NewsAnalyst ForecastEWEdwards Lifesciences4.3559 of 5 stars$77.96-0.1%$79.60+2.1%-17.1%$45.73B$5.52B11.1917,300Positive NewsAnalyst ForecastInsider TradeIDXXIDEXX Laboratories3.39 of 5 stars$520.21+0.4%$536.00+3.0%-2.5%$41.84B$3.93B48.7510,800News CoveragePositive NewsAnalyst ForecastRMDResMed4.1042 of 5 stars$252.38+0.3%$258.83+2.6%+12.5%$37.01B$5.02B29.808,160Positive NewsInsider TradeDXCMDexCom4.736 of 5 stars$86.73+1.5%$98.11+13.1%-35.0%$34.01B$4.15B60.657,600Positive NewsAnalyst ForecastSTESTERIS4.5553 of 5 stars$251.81+0.1%$264.00+4.8%+5.6%$24.74B$5.40B53.4616,000Analyst Upgrade Related Companies and Tools Related Companies Abbott Laboratories Alternatives Intuitive Surgical Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BSX) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BSX Stock Free BSX Stock Alerts